About Tocagen, Inc. (adapted from Tocagen, Inc. prospectus):
They are a clinical-stage, cancer-selective gene therapy company focused on developing first-in-class, broadly-applicable product candidates designed to activate a patients immune system against their own cancer from within.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.